Naveen Pemmaraju

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 130

Top Venues

American journal of hematology

Cancer

Blood advances

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Fady Gh Haddad, Koiji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace S Hwang, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A Abbas, Nicholas James Short, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO oncology practice (2024)
Hannah Goulart, Lucia Masarova, Ruben A Mesa, Claire N Harrison, Jean-Jacques Kiladjian, Naveen Pemmaraju
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature. British journal of haematology 205 (1) (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Wei-Ying Jen, Marina Y Konopleva, Naveen Pemmaraju
Tagraxofusp, a first-in-class CD123-targeted agent: Five-year postapproval comprehensive review of the literature. Cancer 130 (13) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38 (5) (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S Stein, Soheil Meshinchi, Craig A Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I Mughal, Anna B Pawlowska
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients. EJHaem 5 (1) (2024)
Wei-Ying Jen, Marina Y Konopleva, Naveen Pemmaraju
Tagraxofusp, a first-in-class CD123-targeted agent: Five-year postapproval comprehensive review of the literature. Cancer 130 (13) (2024)
Nicholas James Short, Elias J Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M Kantarjian
A Phase 1/2 Study of Mini-Hyper-CVD plus Venetoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood advances (2024)
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S Stein, Soheil Meshinchi, Craig A Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I Mughal, Anna B Pawlowska
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients. EJHaem 5 (1) (2024)
Hannah Goulart, Lucia Masarova, Ruben A Mesa, Claire N Harrison, Jean-Jacques Kiladjian, Naveen Pemmaraju
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature. British journal of haematology (2024)
Hannah Goulart, Lucia Masarova, Ruben A Mesa, Claire N Harrison, Jean-Jacques Kiladjian, Naveen Pemmaraju
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature. British journal of haematology 205 (1) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Wei-Ying Jen, Elias J Jabbour, Nicholas James Short, Ghayas C Issa, Fady Gh Haddad, Nitin Jain, Naveen Pemmaraju, Naval G Daver, Lucia Masarova, Gautam Borthakur, Kelly Sharon Chien, Rebecca Garris, Hagop M Kantarjian
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American journal of hematology (2024)
Ayalew Tefferi, Giovanni Barosi, Francesco Passamonti, Juan Carlos Carlos Hernández-Boluda, Prithviraj Bose, Konstanze Döhner, Martin Ellis, Naseema Gangat, Jacqueline S Garcia, Heinz Gisslinger, Jason Gotlib, Paola Guglielmelli, Vikas K Gupta, Claire N Harrison, Elizabeth O Hexner, Gabriela S Hobbs, Jean-Jacques Kiladjian, Steffen Koschmieder, Nicolaus M Kröger, Andrew T Kuykendall, Giuseppe Gaetano Loscocco, John O Mascarenhas, Lucia Masarova, Ruben A Mesa, Barbara Mora, Olatoyosi Odenike, Stephen T Oh, Animesh D Pardanani, Anand Ashwin Patel, Naveen Pemmaraju, Alessandro Rambaldi, Raajit K Rampal, Shireen Sirhan, Natasha Szuber, Moshe Talpaz, Pankit Vachhani, Alessandro M Vannucchi, Tiziano Barbui
Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis. Blood (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer (2024)
Naveen Pemmaraju, Yazan F Madanat, David A Rizzieri, Salman Fazal, Raajit K Rampal, Gabriel Mannis, Eunice S Wang, James M Foran, Andrew A Lane
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Leukemia & lymphoma 65 (5) (2024)
Hannah Goulart, Lucia Masarova, Ruben A Mesa, Claire N Harrison, Jean-Jacques Kiladjian, Naveen Pemmaraju
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature. British journal of haematology 205 (1) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer 130 (15) (2024)
Wei-Ying Jen, Marina Y Konopleva, Naveen Pemmaraju
Tagraxofusp, a first-in-class CD123-targeted agent: Five-year postapproval comprehensive review of the literature. Cancer (2024)
Hannah Goulart, Lucia Masarova, Ruben A Mesa, Claire N Harrison, Jean-Jacques Kiladjian, Naveen Pemmaraju
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature. British journal of haematology (2024)
Nicholas James Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Fady Nasr, Fadi G Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J Yang, Naveen Pemmaraju, Maro Ohanian, William G Wierda, Guillermo Montalban-Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood advances 8 (4) (2024)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, Elias J Jabbour, Nicholas James Short, Jing Ning, Lianchun Xiao, Naveen Pemmaraju, Courtney D D DiNardo, Tapan Mahendra Kadia, Kayleigh R Marx, Guillermo Garcia Manero, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Association between bariatric surgery and outcomes in chronic myeloid leukemia. Cancer (2023)
Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval G Daver, Koiji Sasaki, Helen T Chifotides, Lingsha Zhou, Hagop M Kantarjian, Zeev Estrov, Srdan Verstovsek
The role of therapy in the outcome of patients with myelofibrosis. Cancer (2023)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ziyi Li, Danielle Hammond, Kelly Sharon Chien, Juan Jose Rodriguez-Sevilla, Koiji Sasaki, Elias Jabbour, Courtney DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop Kantarjian, Guillermo Garcia Manero
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Branko Cuglievan, Jeremy Connors, Jiasen He, Sajad Jawad Khazal, Sireesha Yedururi, Julia Dai, Sofia Garces, Andrés E Quesada, Michael Roth, Miriam B Garcia, David C McCall, Amber Gibson, Dristhi Ragoonanan, Demetrios Petropoulos, Priti Tewari, Cesar Nunez, Kris M Mahadeo, Sarah K Tasian, Adam J Lamble, Anna Pawlowska, Danielle Hammond, Abhishek Maiti, Fadi G Haddad, Jayatsu Senapati, Naval G Daver, Naseema Gangat, Marina Y Konopleva, Soheil Meshinchi, Naveen Pemmaraju
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia (2023)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D D DiNardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)
Jan Philipp Bewersdorf, Joan How, Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, John O Mascarenhas, Raajit K Rampal
Moving towards disease modification in polycythemia vera. Blood (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Bing Z Carter, Po Yee Mak, Muharrem Muftuoglu, Wenjing Tao, Ke Baozhen, Jingqi Pei, Andrea D Bedoy, Lauren B Ostermann, Yuki Nishida, Sevinj Isqandarova, Mary Sobieski, Nghi Nguyen, Reid T Powell, Margarita Martinez-Moczyemba, Clifford Stephen, Mahesh Basyal, Naveen Pemmaraju, Steffen Boettcher, Benjamin L Ebert, Elizabeth J Shpall, Barbara P Wallner, Robert Morgan, Georgios Ioannis Karras, Ute Moll, Michael Andreeff
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells. Blood (2023)
Phillip A Thompson, Michael J Keating, Alessandra Ferrajoli, Nitin Jain, Christine B Peterson, Naveen Garg, Sa A Wang, Jeffrey L Jorgensen, Tapan Mahendra Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas James Short, William G Wierda
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Guillermo Montalban Bravo, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Farhad Ravandi, Kelly Sharon Chien, Naveen Pemmaraju, Danielle Hammond, Xiao Qin Dong, Xuelin Huang, Heather Schneider, Rosmy John, Rashmi Kanagal-Shamana, Sanam Loghavi, Hagop Kantarjian, Guillermo Garcia Manero
Phase 1/2 study of CPX-351 for patients with Int-2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents. British journal of haematology (2023)
Fady Gh Haddad, Koiji Sasaki, Aram Bidikian, Ghayas C Issa, Tapan Mahendra Kadia, Nitin Jain, Yesid Alvarado, Nicholas James Short, Naveen Pemmaraju, Sanam Loghavi, Keyur P Patel, Rashmi Kanagal-Shamana, Musa Ylimaz, Lucia Masarova, Elias J Jabbour, Hagop M Kantarjian
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era. American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology (2023)
Hannah C Beird, Cheng Cameron Yin, Joseph D Khoury, Sherry R Pierce, Hussein A Abbas, Li Zhao, Anna Skwarska, Muzaffar H Qazilbash, Marina Y Konopleva, Andrew Futreal, Naveen Pemmaraju
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm. Blood advances (2023)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban-Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan M Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven Mitchell Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D D DiNardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Andrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, Jada Lauren N Garzon, Ilene Galinsky, Emilie W Baxter, Rebecca Leonard, Daniel J DeAngelo, Marlise R Luskin, Christopher R Reilly, Maximilian Stahl, Richard M Stone, Rahul S Vedula, Martha Wadleigh, Eric S Winer, Tariq I Mughal, Christopher Brooks, Ira V Gupta, Kristen E Stevenson, Donna S Neuberg, Siyang Ren, Julia H Keating, Marina Y Konopleva, Anthony S Stein, Naveen Pemmaraju
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia. Blood advances (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Christine E Birdwell, Warren C Fiskus, Tapan Mahendra Kadia, Christopher P Mill, Koiji Sasaki, Naval G Daver, Courtney D D DiNardo, Naveen Pemmaraju, Gautam Borthakur, John A Davis, Kaberi Das, Sunil Sharma, Stephen Horrigan, Xinjia Ruan, Xiaoping Su, Joseph D Khoury, Hagop Kantarjian, Kapil N Bhalla
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression. Leukemia (2023)
Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas James Short, Ghayas C Issa, Abhishek Maiti, Hussein A Abbas, Naval G Daver, Naveen Pemmaraju, Sherry A Pierce, Kelly Sharon Chien, Koiji Sasaki, Tapan M Kadia, Danielle Hammond, Gautam Borthakur, Keyur Pravinchandra Patel, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia-Manero, Courtney D D DiNardo
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood (2023)
Naveen Pemmaraju, Jacqueline S Garcia, Andrew Charles Perkins, Jason G Harb, Andrew J Souers, Michael E Werner, Christopher M Brown, Francesco Passamonti
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-X L /BCL-2 inhibition with navitoclax. Cancer (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Jayastu Senapati, Elias J Jabbour, Marina Y Konopleva, Nicholas James Short, Guillin Tang, Naval G Daver, Partow Kebriaei, Tapan Mahendra Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtney D D DiNardo, Koiji Sasaki, Gautam Borthakur, Beenu Thakral, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Farhad Ravandi, Kathryn G Roberts, Charles G Mullighan, Hagop M Kantarjian, Nitin Jain
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO precision oncology 7 (2023)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Jayastu Senapati, Mahran Shoukier, Guillermo Garcia Manero, Xuemei Wang, Keyur Patel, Tapan Mahendra Kadia, Farhad Ravandi, Naveen Pemmaraju, Maro Ohanian DO, Naval G Daver, Courtney D D DiNardo, Yesid Alvarado, Jeffrey Aldrich, Gautam Borthakur
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia. American journal of hematology 97 (5) (2022)
Gautam Borthakur, Farhad Ravandi, Keyur Patel, Xuemei Wang, Tapan Mahendra Kadia, Courtney D D DiNardo, Guillermo Garcia Manero, Naveen Pemmaraju, Elias J Jabbour, Koichi Takahashi, Maro Ohanian DO, Naval G Daver, Yesid Alvarado, Mark Brandt, Sherry Pierce, Hagop M Kantarjian
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients. American journal of hematology 97 (11) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology (2022)
Daniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamana, Gautam Borthakur, Guillermo Montalban Bravo, Naval G Daver, Courtney D D DiNardo, Nicholas James Short, Musa Ylimaz, Naveen Pemmaraju, Koichi Takahashi, Elias J Jabbour, Sherry Pierce, Marina Y Konopleva, Kapil N Bhalla, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes. American journal of hematology 97 (12) (2022)
Naveen Pemmaraju, Kendra L Sweet, Anthony S Stein, Eunice S Wang, David A Rizzieri, Sumithira Vasu, Todd L Rosenblat, Christopher L Brooks, Nassir Habboubi, Tariq I Mughal, Hagop M Kantarjian, Marina Y Konopleva, Andrew A Lane
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Naveen Pemmaraju, Hagop M Kantarjian, Kendra L Sweet, Eunice S Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Y Konopleva, Arthur E Frankel, Vikas K Gupta, Ruben A Mesa, Matthew L Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James R Mason, Maria Teresa García-Romero, Norma C Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland Bruno Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K Rampal, Marcos de Lima, James M Foran, Amir T Fathi, Aric C Hall, Meagan A Jacoby, Jeffrey E Lancet, Gabriel N Mannis, Anthony S Stein, Alice S Mims, David A Rizzieri, Rebecca L Olin, Alexander E Perl, Gary J Schiller, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew J Wieduwilt, Naval G Daver, Farhad Ravandi, Sumithira Vasu, Monica L Guzman, Gail J Roboz, Joseph D Khoury, Muzaffar H Qazilbash, Leomar Y Ballester, Branko Cuglievan, Yazan F Madanat, Mohamed A Kharfan-Dabaja, Anna B Pawlowska, Justin Taylor, Martin S Tallman, Prajwal Dhakal, Andrew A Lane
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood (2022)
Mahsa Khanlari, Cheng Cameron Yin, Koichi Takahashi, Curtis A Lachowiez, Guillin Tang, Sanam Loghavi, Ismael Bah, Wei Wang, Sergej Konoplev, L Jeffrey Medeiros, Naveen Pemmaraju, Joseph D Khoury, Sa A Wang
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia 36 (5) (2022)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Jeffrey Skinner, Sara Dellasala, Musa Ylimaz, Alessandra Ferrajoli, Prithviraj Bose, Philip Thompson, Yesid Alvarado, Nitin Jain, Guillermo Garcia Manero, Koichi Takahashi, Gautam Borthakur, Naveen Pemmaraju, Sherry Pierce, Hagop M Kantarjian
Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. American journal of hematology 97 (11) (2022)
Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval G Daver, Koiji Sasaki, Helen T Chifotides, Lingsha Zhou, Hagop M Kantarjian, Zeev E Estrov, Srdan Verstovsek
Improved survival of patients with myelofibrosis in the last decade: Single-center experience. Cancer 128 (8) (2022)
Claire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, James M Foran, Srdan Verstovsek, Catriona Jamieson, Ruben A Mesa, Ellen K Ritchie, Srinivas K Tantravahi, Pankit Vachhani, Casey L O'Connell, Rami S Komrokji, Jason Harb, Jessica E Hutti, Leanne Holes, Abdullah A Masud, Silpa Nuthalapati, Jalaja Potluri, Naveen Pemmaraju
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (15) (2022)
Tapan Mahendra Kadia, Patrick K Reville, Xuemei Wang, Caitlin R Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval G Daver, Courtney D DiNardo, Koiji Sasaki, Ghayas C Issa, Maro Ohanian DO, Guillermo Montalban-Bravo, Nicholas James Short, Nitin Jain, Alessandra Ferrajoli, Kapil N Bhalla, Elias J Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal-Shamana, Sairah A Ahmed, Michael Andreeff, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Elodie Bôle-Richard, Naveen Pemmaraju, Blandine Caël, Etienne Daguindau, Andrew A Lane
CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 14 (9) (2022)
Nitin Jain, Jayastu Senapati, Beenu Thakral, Alessandra Ferrajoli, Phillip A Thompson, Jan A Burger, Sreyashi Basu, Tapan M Kadia, Naval G Daver, Gautam Borthakur, Marina Konopleva, Naveen Pemmaraju, Erin M Parry, Catherine J Wu, Joseph D Khoury, Carlos E Bueso-Ramos, Naveen Garg, Xuemei Wang, Wanda Lopez, Ana Ayala, Susan M O'Brien, Hagop M Kantarjian, Michael J Keating, James P Allison, Padmanee Sharma, William G Wierda
A Phase 2 Study of Nivolumab Combined with Ibrutinib in Patients with Diffuse Large B-cell Richter Transformation of CLL. Blood advances (2022)
Ijele J Adimora, Nathaniel R Wilson, Naveen Pemmaraju
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics. Cancer 128 (16) (2022)
Curtis A Lachowiez, Patrick K Reville, Hagop M Kantarjian, Elias J Jabbour, Gautam Borthakur, Naval G Daver, Ghayas C Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guillin Tang, Keyur P Patel, Jeffrey Medeiros, Hussein A Abbas, Fady Gh Haddad, Daniel Hammond, Nicholas James Short, Abhishek Maiti, Musa Ylimaz, Koiji Sasaki, Koichi Takahashi, Naveen Pemmaraju, Marina Y Konopleva, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Sanam Loghavi, Courtney D D DiNardo
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 97 (11) (2022)
Wei Wang, Jie Xu, Joseph D Khoury, Naveen Pemmaraju, Hong Fang, Roberto N Miranda, C Cameron Yin, Siba El Hussein, Fuli Jia, Zhenya Tang, Shimin Hu, Marina Konopleva, L Jeffrey Medeiros, Sa A Wang
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 14 (14) (2022)
Naveen Pemmaraju, Srdan Verstovsek, Ruben A Mesa, Vikas Gupta, Jacqueline S Garcia, Joseph Michael Scandura, Stephen T Oh, Francesco Passamonti, Konstanze Döhner, Adam J Mead
Defining disease modification in myelofibrosis in the era of targeted therapy. Cancer 128 (13) (2022)
Alexandre Bazinet, Faezeh Darbaniyan, Tapan Mahendra Kadia, Sangeetha Venugopal, Rashmi Kanagal-Shamana, Courtney D D DiNardo, Gautam Borthakur, Elias J Jabbour, Naval G Daver, Naveen Pemmaraju, Marina Y Konopleva, Farhad Ravandi, Koiji Sasaki, Kelly S Chien, Danielle Hammond, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer (2022)
Kunhwa Kim, Marina Y Konopleva, Courtney D D DiNardo, Gautam Borthakur, Sanam Loghavi, Guillin Tang, Naval G Daver, Naveen Pemmaraju, Elias J Jabbour, Caitlin R Rausch, Musa Ylimaz, Koiji Sasaki, Nicholas James Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Mahendra Kadia
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American journal of hematology 97 (7) (2022)
Musa Ylimaz, Hagop M Kantarjian, Nicholas James Short, Patrick K Reville, Marina Y Konopleva, Tapan Mahendra Kadia, Courtney D D DiNardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias J Jabbour, Nitin Jain, Ghayas C Issa, Koichi Takahashi, Koiji Sasaki, Maro Ohanian, Sherry Pierce, Guillin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Sa A Wang, Guillermo Garcia Manero, Michael Andreeff, Farhad Ravandi, Naval G Daver
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood cancer journal 12 (5) (2022)
Naveen Pemmaraju, Claire Harrison, Vikas Gupta, Srdan Verstovsek, Bart Scott, Stephen T Oh, Francesca Palandri, Haifa Kathrin Al-Ali, Marta Sobas, Mary Frances McMullin, Ruben Mesa, Sarah Buckley, Karisse Roman-Torres, Alessandro Vannucchi, Abdulraheem Yacoub
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis. EJHaem 3 (4) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Ghayas C Issa, Aram Bidikian, Sangeetha Venugopal, Marina Y Konopleva, Courtney D D DiNardo, Tapan M Kadia, Gautam Borthakur, Elias J Jabbour, Naveen Pemmaraju, Musa Yilmaz, Nicholas James Short, Abhishek Maiti, Koiji Sasaki, Lucia Masarova, Sherry R Pierce, Koichi Takahashi, Guilin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Michael Andreeff, Kapil N Bhalla, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M Kantarjian, Naval G Daver
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML. Blood advances (2022)
Courtney D D DiNardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Tapan Mahendra Kadia, Naval G Daver, Lianchun Xiao, Maria Adeoti, Nicholas James Short, Koji Sasaki, Sa A Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Ylimaz, Nitin Jain, Michael Andreeff, Guillermo Garcia Manero, Steven Kornblau, Farhad Ravandi, Elias J Jabbour, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia. American journal of hematology 97 (8) (2022)
Siba El Hussein, Mariko Yabe, Wei Wang, Naveen Pemmaraju, Sanam Loghavi, Fatima Zahra Jelloul, Hong Fang, L Jeffrey Medeiros, W Richard Burack, Andrew G Evans, Jane L Liesveld, John M Bennett
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms. EJHaem 3 (3) (2022)
Naveen Pemmaraju, Nathaniel R Wilson, Guillermo Garcia-Manero, Koiji Sasaki, Joseph D Khoury, Nitin Jain, Gautam Borthakur, Farhad Ravandi, Naval G Daver, Tapan Kadia, Courtney D D DiNardo, Elias Jabbour, Sherry Pierce, Muzaffar Qazilbash, Marina Y Konopleva, Hagop Kantarjian
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD. Blood advances 6 (10) (2022)
Sangeetha Venugopal, Gautam Borthakur, Naval G Daver, Courtney D D DiNardo, Naveen Pemmaraju, Nicholas J Short, Hussein A Abbas, Guillermo Garcia-Manero, Marina Y Konopleva, Farhad Ravandi, Tapan M Kadia
Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside-based low-intensity therapy. Blood advances 6 (19) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Mehrnoosh Tashakori, Joseph D Khoury, Mark J Routbort, Keyur Pravinchandra Patel, Sa A Wang, Chi Young Ok, Siba El Hussein, Rashmi Kanagal-Shamana, Rajyalakshmi Luthra, Shimin Hu, Pei Lin, Naveen Pemmaraju, Prithviraj Bose, Srdan Verstovsek, Carlos E Bueso-Ramos, L Jeffrey Medeiros, Sanam Loghavi
Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (11) (2022)
Patrick K Reville, Koiji Sasaki, Hagop M Kantarjian, Naval G Daver, Musa Ylimaz, Courtney D D DiNardo, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Rohtesh S Mehta, Sherry Pierce, Sergej N Konoplev, Joseph D Khoury, Guillermo Garcia Manero, Marina Y Konopleva, Elias Jabbour, Farhad Ravandi, Tapan Mahendra Kadia
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 97 (3) (2022)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Jorge E Cortes, Marina Y Konopleva, Naveen Pemmaraju, Yesid Alvarado, Musa Ylimaz, Gautam Borthakur, Courtney D D DiNardo, Nitin Jain, Naval G Daver, Nicholas James Short, Elias J Jabbour, Hagop Kantarjian
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. American journal of hematology 97 (7) (2022)
Katsuhiro Togami, Sun Sook Chung, Vikas Madan, Christopher A G Booth, Christopher M Kenyon, Lucia Cabal-Hierro, Justin Taylor, Sunhee S Kim, Gabriel K Griffin, Mahmoud Ghandi, Jia Li, Yvonne Y Li, Fanny Angelot-Delettre, Sabeha Biichle, Michael Seiler, Silvia Buonamici, Scott B Lovitch, Abner Louissaint, Elizabeth A Morgan, Fabrice Jardin, Pier Paolo Piccaluga, David M Weinstock, Peter S Hammerman, Henry Yang, Marina Konopleva, Naveen Pemmaraju, Francine Garnache-Ottou, Omar Abdel-Wahab, H Phillip Koeffler, Andrew A Lane
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis. Cancer discovery (2021)
Naveen Pemmaraju, Nathaniel R Wilson, Joseph D Khoury, Nitin Jain, Naval G Daver, Sherry Pierce, Elias Jabbour, Tapan Kadia, Courtney D D DiNardo, Guillermo Garcia-Manero, Muzaffar Qazilbash, Marina Y Konopleva, Hagop Kantarjian
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm. Blood 138 (15) (2021)
Kapil Saxena, Shelley M Herbrich, Naveen Pemmaraju, Tapan Mahendra Kadia, Courtney D D DiNardo, Gautam Borthakur, Sherry A Pierce, Elias J Jabbour, Sa A Wang, Carlos Bueso-Ramos, Sanam Loghavi, Guillin Tang, Cora M Cheung, Lynette Alexander, Steven Kornblau, Michael Andreeff, Guillermo Garcia Manero, Farhad Ravandi, Marina Y Konopleva, Naval G Daver
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer 127 (20) (2021)
Warren C Fiskus, Christopher P Mill, Behnam Nabet, Dimuthu Perera, Christine Birdwell, Taghi Manshouri, Bernardo Lara, Tapan Mahendra Kadia, Courtney D D DiNardo, Koichi Takahashi, Naval G Daver, Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Steven Mitchell Kornblau, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Sunil Sharma, Matthew Stubbs, Xiaoping Su, Michael R Green, Cristian Coarfa, Srdan Verstovsek, Joseph D Khoury, Christopher R Vakoc, Kapil N Bhalla
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells. Blood cancer journal 11 (5) (2021)
Abhishek Maiti, Courtney D D DiNardo, Wei Qiao, Tapan Mahendra Kadia, Elias J Jabbour, Caitlin R Rausch, Naval G Daver, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Musa Yilmaz, Yesid Alvarado, Kathryn S Montalbano, Allison Wade, Rita E Maduike, Julio A Guerrero, Kenneth Vaughan, Carol A Bivins, Sherry Pierce, Jing Ning, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis. Cancer 127 (22) (2021)
Courtney D D DiNardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan Mahendra Kadia, Naval G Daver, Maria Adeoti, Nicholas James Short, Koiji Sasaki, Sa Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Yilmaz, Nitin Jain, Michael Andreeff, Elias J Jabbour, Guillermo Garcia Manero, Steven Mitchell Kornblau, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Nitin Jain, Abhishek Maiti, Farhad Ravandi, Marina Y Konopleva, Naval G Daver, Tapan Mahendra Kadia, Naveen Pemmaraju, Nicholas James Short, Partow Kebriaei, Jing Ning, Jorge E Cortes, Elias J Jabbour, Hagop Kantarjian
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. American journal of hematology 96 (8) (2021)
Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Marina Y Konopleva, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Rashmi Kanagal-Shamana, Xuemei Wang, Xuelin Huang, Sherry Pierce, Caitlin R Rausch, Jan Burger, Alessandra Ferrajoli, Nitin Jain, Uday Popat, Zeev Estrov, Srdan Verstovsek, Elias J Jabbour, Guillermo Garcia Manero, Hagop Kantarjian
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. American journal of hematology 96 (8) (2021)
Naveen Pemmaraju, Nathaniel R Wilson, Theresa Clementi Doan, Wei Qiao, Susan K Peterson, Vicky Zoeller, Andrew Schorr, Srdan Verstovsek
Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era. Leukemia & lymphoma 62 (9) (2021)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Faezeh Darbaniyan, Maria Tariq Siddiqui, Koiji Sasaki, Yue Wei, Hui Yang, Kelly Sharon Chien, Kiran Naqvi, Elias J Jabbour, Tapan Mahendra Kadia, Naval G Daver, Courtney D D DiNardo, Farhad Ravandi, Naveen Pemmaraju, Prithviraj Bose, Srdan Verstovsek, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Kim-Anh Do, Hagop M Kantarjian, Guillermo Garcia Manero
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS). American journal of hematology 96 (7) (2021)

Naveen Pemmaraju.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naveen Pemmaraju